Cargando…
Corrigendum: A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma
Autores principales: | Radhakrishnan, Aneesha, Nanjappa, Vishalakshi, Raja, Remya, Sathe, Gajanan, Puttamallesh, Vinuth N., Jain, Ankit P., Pinto, Sneha M., Balaji, Sai A., Chavan, Sandip, Sahasrabuddhe, Nandini A., Mathur, Premendu P., Kumar, Mahesh M., Prasad, T. S. Keshava, Santosh, Vani, Sukumar, Geethanjali, Califano, Joseph A., Rangarajan, Annapoorni, Sidransky, David, Pandey, Akhilesh, Gowda, Harsha, Chatterjee, Aditi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484017/ https://www.ncbi.nlm.nih.gov/pubmed/28650432 http://dx.doi.org/10.1038/srep46864 |
Ejemplares similares
-
A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma
por: Radhakrishnan, Aneesha, et al.
Publicado: (2016) -
Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells
por: Raja, Remya, et al.
Publicado: (2016) -
Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor
por: Solanki, Hitendra S., et al.
Publicado: (2018) -
Correction: Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor
por: Solanki, Hitendra S., et al.
Publicado: (2021) -
Phosphotyrosine profiling of curcumin-induced signaling
por: Sathe, Gajanan, et al.
Publicado: (2016)